Now the other cool thing here is, as announced in a press release last week, the Company has filed for a patent covering A2-73’s use to lower high blood pressure.
Anavex has received the patent (see below). As an aside, I often find Bishop's commentary lacking in accuracy/completeness ... this is one example.
Amen Abew! Does this officially mean Tom Bishop has taken a position in Anavex? Not sure why these analysts put out many great “reports” over the years only to disclose no position in fine print down at the bottom.
#WGT Cheers
PS wheres the Adas cog data and start of the undisclosed rare disease, validating all our hard work? He! He! he!